Dr
Fiona
Christie

Patent Attorney

Leeds Office

Telephone. +44(0) 113 233 0100
Email. [email protected]

Experience

Since joining HGF in 2014, Fiona has worked on drafting and prosecuting patent applications in a range of practice areas in the chemical field including pharmaceuticals, physical chemistry and nanomaterials.

Prior to joining HGF, Fiona obtained a First Class MSci in Forensic and Analytical Chemistry from the University of Strathclyde in 2009, during which she undertook a one-year industrial placement at Pfizer.

Fiona then moved to Cambridge University to accept a place on the Nanoscience and Technology Doctoral Training Centre. Fiona's doctoral research involved investigating routes to understanding the aggregation behaviour of insulin through the use of supramolecular chemistry. Following the submission of her thesis, Fiona completed a short research internship at the Ecole Normale Superieure in Paris, France working towards the manipulation of particle deposition in evaporating droplets.

Fiona qualified as a Chartered Patent Attorney and as a European Patent Attorney in 2019.

Specialisms

  • Electrochemistry
  • Pharmaceutical technologies
  • Physical chemistry

Industries

  • Pharmaceuticals icon Pharmaceuticals

Services

  • Patents

Qualifications

Patent Attorney

Chartered (UK)
European


MSCI

Forensic and Analytical Chemistry, University of Strathclyde, 2009

PHD

Chemistry, University of Cambridge, 2014

POSTGRADUATE DIPLOMA OR CERTIFICATE

PGCert IP, University of Bournemouth

Related News

Managing Intellectual Property IP Stars & Firm Rankings 2021

Managing Intellectual Property IP Stars 2021, comprising the highly recommended IP professionals, has now been published. HGF is delighted to have 14 European attorneys listed. IP STARS is the leading …

Read article

Medical technology most patented subject matter at EPO in 2020

Pharmaceutical and biotechnology patent applications also make top 10 most patented. Recent statistics published by the EPO show that a total of 14,295 European patent applications were filed in 2020 …

Read article

The EPO ‘How To’ guide for antibody applications in Europe

The 2021 EPO Guidelines provide much needed guidance on how to protect antibodies in Europe. Biological drugs including therapeutic antibodies have become increasingly important to the pharmaceutical industry. The European …

Read article

Personalised drug patenting in Europe

Opportunities for additional pharmaceutical product patent protection in Europe, based on the use of a drug to treat a patient exhibiting a biomarker indicative of drug response. Recent years have …

Read article

The Internet of Medical Things

Exploring the growth of patents for connected medical devices, and how best to protect them. The Internet of Things (IoT) is expected to change our lives by creating a connected …

Read article

Covid-19 vaccine patent waivers

To waive, or not to waive, that is the question. The earliest identified date of a patient presenting with symptoms of a “novel coronavirus” in Wuhan, China is reported to …

Read article
Event - 9th June 2021

Webinar: Developing effective patent strategies for personalised medical devices in Europe and the US

HGF in Europe and Knobbe Martens in the US are holding a joint webinar on 9th June. In this webinar we will explore considerations for implementing an effective strategy to …

Event details
Event - 25th May 2021

IAM webinar: How to capitalise on the 5G healthcare revolution

HGF Partner Dr Susan Keston and Senior Patent Attorney Dr Sofie McPherson will be presenting a webinar ‘How to capitalise on the 5G healthcare revolution’ on 25th May. This session will explore how 5G …

Event details

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.